In Vitro and in Vivo Anti-Leukemic Efficacy of Cyclic AMP Modulating Agents Against Human Leukemic B-cell Precursors

References

• Jegasothy B.V., Namba Y., Walksman B.H. Regulatory substances produced by lymphocytes. IDS inhibits stimulated lymphocyte proliferation by activation of membrane adenylate cyclase at a restriction point in late GI. Immunochemistry 1978; 15: 551
   PubMedGoogle Scholar
• Wang T., Sheppard R., Foker J.E. Rise and fall of cyclic AMP required for onset of lymphocyte DNA synthesis. Science 1978; 201: 155
   PubMed Web of Science ®Google Scholar
• Muraguchi A., Miyazaki K., Kehrl J.H., Fauci A.S. Inhibition of human B cell activation by diterpine forskolin: Interference with B cell growth factor induced Gl to S transition of the B cell cycle. J. Immunol. 1984; 133: 1283–1287
   PubMed Web of Science ®Google Scholar
• Baker P.E., Fahey J.V., Munck A. Prostaglandin inhibition of T cell proliferation is mediated at two levels. Cell. Immunol. 1981; 61: 52
   PubMed Web of Science ®Google Scholar
• DosReis G.A., Nobrga A.F., deCarvalho R.P. Purinergic modulation of T lymphocyte activation: differential susceptibility of distinct activation steps and correlation with intracellular 3′,5′ cAMP accumulation. Cell. Immunol. 1986; 101: 213
   PubMed Web of Science ®Google Scholar
• Blomhoff H.K., Smeland E.B., Bfiske K., Blomhoff R., Ruud E., Bjoro T., Pfeifer-Olson S., Watt R., Funderud S., Godal T., Ohlson R. Cyclic AMP mediated suppression of normal and neoplastic B cell proliferation is associated with regulation of myc and Ha-ras protooncogenes. J. Cell. Physiol. 1987; 131: 426
   PubMed Web of Science ®Google Scholar
• McConkey D., Orrenius S., Jondal M. Agents that elevate cAMP stimulate DNA fragmentation in thymocytes. J. Immunol. 1990; 145: 1227
   PubMed Web of Science ®Google Scholar
• Kizaki H., Suzuki K., Tadakuma T., Ishimura Y. Adenosine receptor-mediated accumulation of cyclic AMP-induced T lymphocyte death through internucleosomal DNA cleavage. J. Biol. Chem. 1990; 265: 5280
   PubMed Web of Science ®Google Scholar
• McConkey D.J., Orrenius S., Okret S., Jondal M. Cyclic AMP potentiates glucocorticoid indued endogenous endonuclease activation in thymocytes. The FASEB J 1993; 7: 580
   PubMed Web of Science ®Google Scholar
• Albert D.A. The effect of cyclic AMP on the regulation of c-myc expression in T lymphomacells. J. Clin. Invest. 1995; 95: 1490–1496
   PubMed Web of Science ®Google Scholar
• Lomo J., Blomhoff H.K., Beiske K., Stokke T., Smeland E.B. TGF beta 1 and cyclic AMP promote apoptosis in resting human B lymphocytes. J. Immunol. 1995; 154: 1634–1643
   PubMed Web of Science ®Google Scholar
• Vintermyr O.K., Boe R., Brustugun O.T., Maronde E., Aakvaag A., Doskeland S.O. Cyclic adenosine monophosphate analogs 8-C1 and 8-NH2-CAMP induce cell death independently of cAMP kinase mediated inhibition of the Gl/S transition in mammary carcinoma cells. Endocrinology 1995; 136: 2513–2520
   PubMed Web of Science ®Google Scholar
• Cho-Chung Y.S., Clair T., Tortora G., Yokozaki H. Role of site-selective cAMP analogs in the control and reversal of malignancy. Pharmacol. Ther. 1991; 50: 1–33
   PubMed Web of Science ®Google Scholar
• Hartwell L. cAMP'ing out. Science 1994; 371: 286
   Google Scholar
• Roger P.P., Rickaert F., Huez G., Authlet M., Hofmann F., Dumont J.E. Microinjection of catalytic subunit of cyclic AMP-dependent kinases triggers acute morphological changes in thyroid epithelial cells. FEBS Lett. 1988; 232: 409–413
   PubMed Web of Science ®Google Scholar
• Cook S.J., McCormick F. Inhibition by cAMP of ras-de-pendent activation of raf. Science 1993; 262: 1069–1072
   PubMed Web of Science ®Google Scholar
• Tokiwa G., Tyers M., Volpe T., Futcher B. Inhibition of Gl cyclin activity by the ras/cAMP pathway in yeast. Nature 1994; 371: 342–345
   PubMed Web of Science ®Google Scholar
• Vintermyr O.K., Gjertsen B.T., Lanotte M., Doskeland S.O. Microinjected catalytic subunit of cAMP dependent protein kinase induces apoptosis in myeloid leukemia cells. Exp. Cell. Res. 1993; 206: 157–161
   PubMed Web of Science ®Google Scholar
• Tortora G., Tagliaferri P., Clair T., Colamonici O., Neckers L.M., Robins R.K., Cho-Chung Y.S. Site-selective cAMP analogs at micromolar concentrations induce growth arrest and differentiation of acute promyelocytic, chronic myelocytic, and acute lymphocytic leukemia cell lines. Blood 1988; 71: 230–233
   PubMed Web of Science ®Google Scholar
• Miller R.P., Lovelance E., Gallo M., Pastan I. Cyclic AMP and cellular growth. Science 1975; 190: 1213–1215
   PubMed Web of Science ®Google Scholar
• Cho-Chung Y.S., Gullino P.M. In vivo inhibition of growth of two hormone-dependent mammary tumors by dibutyryl cyclic AMP. Science 1974; 183: 87–88
   PubMed Web of Science ®Google Scholar
• Uckun F.M., Manivel C., Arthur D., Chelstrom L.M., Finnegan D., Irvin J., Tuel-Ahlgren L., Myers D.E., Gunther R. In vivo efficacy of B43(anti-CD19)-pokeweed antiviral protein im-munotoxin against human pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency. Blood 1992; 79: 2201
   PubMed Web of Science ®Google Scholar
• Uckun F.M., Stewart C.F., Reaman G., Chelstrom L.M., Jin J., Chandan-Langlie M., Waddick K.G., White J., Evans W.E. In vitro and in vivo activity of topotecan against human -B-lineage acute lymphoblastic leukemia cells. Blood 1995; 85: 2817–2828
   PubMed Web of Science ®Google Scholar
• Uckun F.M., Jaszcz W., Chandan-Langlie M., Waddick K.G., Song C.W. Intrinsic radiation resistance of primary clono-genic blasts from children with newly diagnosed B-cell precursor acute lymphoblastic leukemia. J. Clin. Invest. 1993; 91: 1044
   PubMed Web of Science ®Google Scholar
• Uckun F.M., Evans W.E., Forsyth C.J., Waddick K.G., Tuel-Ahlgren L., Chelstrom L., Burkhardt A., Bolen J., Myers D.E. Biotherapy of B cell precursor leukemia by targeting genis-tein to CD19 associated tyrosine kinases. Science 1995; 267: 886
   PubMed Web of Science ®Google Scholar